drugset / Trial / NCT00215449

Study in Patients With COPD

NCT00215449 ↗

Phase 3 Completed 690 enrolled Dey
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the efficacy and safety of the investigational drug in the treatment of COPD in comparison with a placebo.

Timeline

Start
—
Primary completion
2005-12
Completion
2006-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Formoterol Other / unclassified 12 ug Inhaled
Subject Formoterol Other / unclassified 20 ug Inhaled